Structure Therapeutics Inc. Balance Sheet
GPCR / Health Care|4 years of annual SEC 10-K data (FY2022-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 4 fiscal years. All figures from audited SEC 10-K filings.
Structure Therapeutics Inc. had $1.6B in total assets and $1.5B in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 9.77 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash & Equivalents | $799.6M | $169.5M | $129.8M | $26.1M |
| Current Assets | $1.6B | $891.2M | $473.6M | $93.1M |
| PP&E (Net) | $6.7M | $3.5M | $3.2M | $1.0M |
| Total Assets | $1.6B | $903.3M | $482.0M | $97.8M |
| Current Liabilities | $63.3M | $36.0M | $24.7M | $13.0M |
| Shareholders' Equity | $1.5B | $864.8M | $453.0M | -$115.1M |